0000059478-20-000187.txt : 20201210 0000059478-20-000187.hdr.sgml : 20201210 20201210170052 ACCESSION NUMBER: 0000059478-20-000187 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201208 FILED AS OF DATE: 20201210 DATE AS OF CHANGE: 20201210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39746 FILM NUMBER: 201381297 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER NAME: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sigilon Therapeutics, Inc. CENTRAL INDEX KEY: 0001821323 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 474005543 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-336-7540 MAIL ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: STE 600 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_160763763834444.xml FORM 4 X0306 4 2020-12-08 1 0001821323 Sigilon Therapeutics, Inc. SGTX 0000059478 ELI LILLY & Co LILLY CORPORATE CENTER INDIANAPOLIS IN 46285 0 0 1 0 Common Stock 2020-12-08 4 C 0 2444443 A 2444443 D Common Stock 2020-12-08 4 P 0 300000 18 A 2744443 D Series A-3 Convertible Preferred Stock 2020-12-08 4 C 0 1555555 D Common Stock 1555555.0 0 D Series B Convertible Preferred Stock 2020-12-08 4 C 0 888888 D Common Stock 888888.0 0 D Upon the closing of the Issuer's initial public offering, each share of Series A-3 Convertible Preferred Stock and Series B Convertible Preferred Stock (collectively, the "Preferred Stock") automatically converted into shares of the Issuer's common stock without payment or further consideration. There was no expiration date for the Preferred Stock. As a result of the Issuer's initial public offering, the reporting person is no longer a 10% owner of the Issuer and is therefore no longer subject to Section 16 in connection with its transactions in the equity securities of the Issuer. Erin Conway, Assistant Secretary 2020-12-10